Sophie E. Mastenbroek

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Subtyping and staging of Alzheimer's disease from routine structural MRI with PHASE-AD.

Subtyping and staging of Alzheimer's disease from routine structural MRI with PHASE-AD.

Journal: medRxiv : the preprint server for health sciences
Published: July 10, 2026

The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline.

The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline.

Journal: Neurology
Published: May 14, 2026

Characterizing Individuals Fulfilling Clinical Criteria for Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Tertiary Memory Clinic.

Characterizing Individuals Fulfilling Clinical Criteria for Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Tertiary Memory Clinic.

Journal: Neurology
Published: April 16, 2026

Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History study.

Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History study.

Journal: NeuroImage. Clinical
Published: August 12, 2025

Biological classification of memory clinic patients.

Biological classification of memory clinic patients.

Journal: Brain : a journal of neurology
Published: April 14, 2025

Your Alzheimer Risk: How Your Sex and Your Affected Parent's Sex Independently Shape the Odds.

Your Alzheimer Risk: How Your Sex and Your Affected Parent's Sex Independently Shape the Odds.

Journal: Neurology
Published: April 09, 2025

Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participants.

Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participants.

Journal: Acta neuropathologica
Published: March 27, 2025

Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification.

Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification.

Journal: Nature communications
Published: February 21, 2025

Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity.

Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity.

Journal: Neurology
Published: June 11, 2024

Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment.

Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment.

Journal: JAMA neurology
Published: June 10, 2024

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease.

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease.

Journal: Nature communications
Published: March 06, 2024

Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.

Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.

Journal: bioRxiv : the preprint server for biology
Published: December 18, 2023
Showing 1-12 of 17

Last Updated: 09/26/2026